Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/06/2205 : 00GlobeNewswire Inc.HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by TakedaNASDAQ:HCMHUTCHMED China Limited
2024/06/2205 : 00GlobeNewswire Inc.Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024TG:6IVInventiva
2024/06/2205 : 00GlobeNewswire Inc.Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024  EU:IVAInventiva
2024/06/2205 : 00Business WireTakeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal CancerNYSE:TAKTakeda Pharmaceutical Company Ltd
2024/06/2205 : 00GlobeNewswire Inc.Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024  TG:6IVInventiva
2024/06/2205 : 00Business WirePennsylvania American Water Applies for East Dunkard Water Authority Acquisition ApprovalNYSE:AWKAmerican Water Works
2024/06/2205 : 00GlobeNewswire Inc.Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024  EU:IVAInventiva
2024/06/2205 : 00GlobeNewswire Inc.In order to complete Meraki refinancing Baltic Horizon Fund requests for a waiver and bondholders consent under the bond terms and conditions
2024/06/2205 : 00GlobeNewswire Inc.Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024  LSE:0RNKInventiva Sa
2024/06/2205 : 00GlobeNewswire Inc.CoinShares Announces FlowBank Holdings SA Investment ImpairmentTG:3TWCoinShares International Limited
2024/06/2205 : 00GlobeNewswire Inc.Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024EU:IVAInventiva
2024/06/2205 : 00GlobeNewswire Inc.HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda4502.T
2024/06/2205 : 00GlobeNewswire Inc.Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024LSE:0RNKInventiva Sa
2024/06/2205 : 00GlobeNewswire Inc.HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by TakedaNYSE:TAKTakeda Pharmaceutical Company Ltd
2024/06/2205 : 00GlobeNewswire Inc.In order to complete Meraki refinancing Baltic Horizon Fund requests for a waiver and bondholders consent under the bond terms and conditions
2024/06/2204 : 57PR Newswire (Canada)Iconic Niagara Winery Château des Charmes Has Been Sold
2024/06/2204 : 57Business WireQpiAI conclut un financement de présérie A de 6,5 millions de dollars, mené par Yournest et SIDBI Venture Capital, permettant la modélisation et le calcul de l’intelligence à l’aide d’ordinateurs quantiques
2024/06/2204 : 56Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
2024/06/2204 : 54Business WireFrank Zappa & the Mothers of Invention’s Wild Three-hour Concert Recorded Live at the Whisky a Go Go in 1968 out Now as Whisky a Go Go, 1968
2024/06/2204 : 52Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:BMOLFBank of Montreal (PK)
2024/06/2204 : 51Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:BMOLFBank of Montreal (PK)
2024/06/2204 : 50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SQLSeqLL Inc
2024/06/2204 : 50Business WireMica Nguyen Worthy of Cranfill Sumner LLP Submits First-of-its-Kind Claim to NASA Seeking Recovery From Damages Sustained From Space Debris
2024/06/2204 : 49PR Newswire (US)Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolutionNYSE:LLYEli Lilly and Co
2024/06/2204 : 47Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:RYBPFRoyal Bank (PK)
2024/06/2204 : 46Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:BMOLFBank of Montreal (PK)
2024/06/2204 : 45Business WireVertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific SessionsNASDAQ:VRTXVertex Pharmaceuticals Inc
2024/06/2204 : 45PR Newswire (US)Use of Tirzepatide Shown to Improve Sleep Apnea and Cardiovascular Outcomes
2024/06/2204 : 45PR Newswire (US)Common Cholesterol-Lowering Drug Found to Slow Vision Loss in Diabetes Patients
2024/06/2204 : 45PR Newswire (US)Expanded FORWARD Trial Demonstrates Continued Potential for Stem Cell-Derived Islet Cell Therapy to Eliminate Need for Insulin for People with T1D

最近閲覧した銘柄

Delayed Upgrade Clock